Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,025 | 113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $323.56 | 5 | $0 (2024) |
| ABBVIE INC. | $299.81 | 17 | $0 (2024) |
| Novo Nordisk Inc | $185.16 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $133.49 | 9 | $0 (2023) |
| Amgen Inc. | $130.38 | 9 | $0 (2024) |
| PFIZER INC. | $123.26 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $101.42 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $62.82 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $59.09 | 3 | $0 (2024) |
| Lilly USA, LLC | $55.77 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $763.98 | 32 | Supernus Pharmaceuticals, Inc. ($323.56) |
| 2023 | $264.14 | 17 | ABBVIE INC. ($83.06) |
| 2022 | $630.84 | 40 | ABBVIE INC. ($144.74) |
| 2021 | $264.02 | 17 | Biohaven Pharmaceuticals, Inc. ($38.06) |
| 2020 | $90.56 | 6 | Allergan, Inc. ($35.32) |
| 2019 | $11.22 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11.22) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 5 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: PSYCHIATRY | ||||||
| 06/25/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/20/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/28/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: RESPIRATORY | ||||||
| 04/13/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $12.33 | General |
| 01/06/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Gastroenterology | ||||||
| 12/03/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: DIABETES | ||||||
| 02/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: DIABETES | ||||||
| 01/29/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 35 | 45 | $6,948 | $2,315 |
| 2021 | 1 | 11 | 15 | $2,250 | $829.35 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 34 | $5,100 | $1,717 | 33.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 11 | $1,848 | $598.51 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 15 | $2,250 | $829.35 | 36.9% |
About Dr. Jarron Lincoln, DO
Dr. Jarron Lincoln, DO is a Family Medicine healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2012. The National Provider Identifier (NPI) number assigned to this provider is 1255685772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jarron Lincoln, DO has received a total of $2,025 in payments from pharmaceutical and medical device companies, with $763.98 received in 2024. These payments were reported across 113 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,025).
As a Medicare-enrolled provider, Lincoln has provided services to 46 Medicare beneficiaries, totaling 60 services with total Medicare billing of $3,145. Data is available for 2 years (2021–2022), covering 3 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Shelbyville, IN
- Active Since 11/06/2012
- Last Updated 10/04/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255685772
Products in Payments
- Qelbree (Drug) $323.56
- VRAYLAR (Drug) $285.45
- NURTEC ODT (Drug) $126.14
- JARDIANCE (Drug) $119.76
- Otezla (Drug) $107.99
- ENTRESTO (Drug) $87.29
- Ozempic (Drug) $73.94
- TRELEGY ELLIPTA (Drug) $62.82
- ELIQUIS (Drug) $51.98
- UBRELVY (Drug) $49.68
- Heplisav-B (Drug) $48.52
- CAPLYTA (Drug) $47.42
- REXULTI (Drug) $44.00
- INTELLIS ADAPTIVESTIM (Device) $32.14
- Auvelity (Drug) $31.00
- Cologuard Collection Kit (Device) $29.25
- MOUNJARO (Drug) $28.82
- BELSOMRA (Drug) $26.48
- PREVNAR 13 (Biological) $25.13
- Aimovig (Biological) $22.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelbyville
Dr. Ron Creque, Md, MD
Family Medicine — Payments: $15,710
Paul Goodlett, Md, MD
Family Medicine — Payments: $14,867
Dr. David Oligschlaeger, D.o, D.O
Family Medicine — Payments: $11,457
Beth Buchanan, Md, MD
Family Medicine — Payments: $10,835
Dr. Emily Ann Andaya, Md, MD
Family Medicine — Payments: $8,149
Meredith Kehrer, Md, MD
Family Medicine — Payments: $6,265